2021 January-March

Date Presenter


24 March , 2021 Takayuki Chikata
Agerer B, et al. SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8 + T cell response. Sci Immunol. 2021 Mar 4;6(57):eabg6461. doi: 10.1126/sciimmunol.abg6461.
10 March , 2021 Nozomi Kuse
Cadena AM, et al. Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques. Nat Commun. 2021 Mar 5;12(1):1474. doi: 10.1038/s41467-021-21724-0.
24 February, 2021 Hung Nguyen The
Garcia-BatesTM, et al. Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes. EBioMedicine. 2021 Jan;63:103175. doi: 10.1016/j.ebiom.2020.103175.
10 February, 2021 Zhang Yu
Voysey M, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1.
Logunov DY, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021 Feb 20;397(10275):671-681. doi: 10.1016/S0140-6736(21)00234-8.
27 January, 2021
Takayuki Chikata
Hopfensperger K, et al. Convergent Evolution of HLA-C Downmodulation in HIV-1 and HIV-2. mBio. 2020 Jul 14;11(4):e00782-20. doi: 10.1128/mBio.00782-20.
13 January, 2021
Nozomi Kuse
Min-Seok Rha, et al. PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19. Immunity. 2020 Dec 14;S1074-7613(20)30509-4. doi: 10.1016/j.immuni.2020.12.002.